The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Inflammation in COPD and the Effect of Nicotinamide Riboside (ICON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04990869
Recruitment Status : Completed
First Posted : August 5, 2021
Last Update Posted : March 15, 2024
Sponsor:
Collaborators:
Bispebjerg Hospital
Elysium Health
Information provided by (Responsible Party):
Morten Scheibye-Knudsen, University of Copenhagen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 18, 2022
Actual Study Completion Date : August 18, 2022